Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thymidylate synthetase | Starlite/ChEMBL | References |
Mus musculus | thymidylate synthase | Starlite/ChEMBL | References |
Lactobacillus casei | Thymidylate synthase | Starlite/ChEMBL | References |
Lactobacillus casei | Dihydrofolate reductase | Starlite/ChEMBL | References |
Homo sapiens | dihydrofolate reductase | Starlite/ChEMBL | References |
Rattus norvegicus | Dihydrofolate reductase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0584 | 0.5625 | 0.8875 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0623 | 0.6338 | 0.5 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.0623 | 0.6338 | 1 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0623 | 0.6338 | 1 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0623 | 0.6338 | 1 |
Brugia malayi | Dihydrofolate reductase | 0.0623 | 0.6338 | 1 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0822 | 1 | 0.5 |
Echinococcus granulosus | dihydrofolate reductase | 0.0623 | 0.6338 | 1 |
Brugia malayi | thymidylate synthase | 0.0584 | 0.5625 | 0.8875 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0822 | 1 | 0.5 |
Schistosoma mansoni | dihydrofolate reductase | 0.0623 | 0.6338 | 1 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0623 | 0.6338 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.0623 | 0.6338 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0822 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0278 | 0 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0822 | 1 | 1 |
Onchocerca volvulus | 0.0584 | 0.5625 | 0.5 | |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0822 | 1 | 0.5 |
Brugia malayi | dihydrofolate reductase family protein | 0.0623 | 0.6338 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
I50 (binding) | = 0.13 uM | Inhibition of L1210 leukemia thymidylate synthase (TS) enzyme | ChEMBL. | 2704031 |
I50 (binding) | = 7 uM | Inhibition of human WIL2/dihydrofolate reductase activity | ChEMBL. | 2704031 |
IC50 (binding) | = 0.13 uM | Inhibition of L1210 leukemia thymidylate synthase (TS) enzyme | ChEMBL. | 2704031 |
IC50 (binding) | = 0.16 uM | Inhibitory concentration of compound to inhibit Thymidylate synthase (TS) in L1210 cells at conc. of 200 microM | ChEMBL. | 2704030 |
IC50 (binding) | = 0.16 uM | Inhibitory concentration of compound to inhibit Thymidylate synthase (TS) in L1210 cells at conc. of 200 microM | ChEMBL. | 2704030 |
IC50 (binding) | = 0.16 uM | The compound was not tested for inhibition of L1210 Thymidylate synthase due to insolubility | ChEMBL. | 2362285 |
IC50 (functional) | = 0.27 uM | Inhibition of the growth of methotrexate sensitve L1210 leukemia/S cells in culture | ChEMBL. | 2704031 |
IC50 (functional) | = 0.27 uM | Inhibition of the growth of methotrexate sensitve L1210 leukemia/S cells in culture | ChEMBL. | 2704031 |
IC50 (functional) | = 0.4 uM | Tested for 50% inhibition of L1210 cell growth in vitro | ChEMBL. | 2362285 |
IC50 (functional) | = 0.4 uM | Tested for 50% inhibition of L1210 cell growth in vitro | ChEMBL. | 2362285 |
IC50 (binding) | = 7 uM | Inhibition of human WIL2/dihydrofolate reductase activity | ChEMBL. | 2704031 |
IC50 (functional) | = 75 uM | Inhibition of the growth of methotrexate resistant L1210 leukemia/R 81 cells in culture | ChEMBL. | 2704031 |
IC50 (functional) | = 75 uM | Inhibition of the growth of methotrexate resistant L1210 leukemia/R 81 cells in culture | ChEMBL. | 2704031 |
ID50 (functional) | = 0.4 uM | Compound was evaluated for inhibition dose required to inhibit the growth of L1210 cells in culture. | ChEMBL. | 2704030 |
ID50 (functional) | = 0.4 uM | Compound was evaluated for inhibition dose required to inhibit the growth of L1210 cells in culture. | ChEMBL. | 2704030 |
Ki (binding) | = 26 nM | Binding affinity of the compound against thymidylate synthase | ChEMBL. | 1995868 |
Ki (binding) | = 26 nM | Binding affinity of the compound against thymidylate synthase | ChEMBL. | 1995868 |
Ki (binding) | = 2250 nM | Compound was evaluated for the inhibition of partially purified rat liver Dihydrofolate reductase (DHFR) enzyme. | ChEMBL. | 2704030 |
Ki (binding) | = 2250 nM | Compound was evaluated for the inhibition of partially purified rat liver Dihydrofolate reductase (DHFR) enzyme. | ChEMBL. | 2704030 |
Ki (binding) | = 2.5 uM | Binding affinity of the compound against Dihydrofolate reductase | ChEMBL. | 1995868 |
Ki (binding) | = 2.5 uM | Binding affinity of the compound against Dihydrofolate reductase | ChEMBL. | 1995868 |
ND (binding) | = 0.16 uM | The compound was not tested for inhibition of L1210 Thymidylate synthase due to insolubility | ChEMBL. | 2362285 |
Solubility | = 0.043 mg ml-1 | Solubility of the compound at pH 5 | ChEMBL. | 2704030 |
Solubility | > 107 mg ml-1 | Solubility of the compound at pH 7.4 | ChEMBL. | 2704030 |
Toxicity (ADMET) | Renal or hepatic toxicities observed in mice after the intravenous administration of 100 mg/kg | ChEMBL. | 1995868 | |
Toxicity (ADMET) | 0 | Renal or hepatic toxicities observed in mice after the intravenous administration of 100 mg/kg | ChEMBL. | 1995868 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 2362285 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
4 literature references were collected for this gene.